Jupiter Neurosciences, Inc.
JUNS
$3.16
-$0.12-3.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.20M | -9.18M | -8.64M | -7.60M | -5.90M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 766.50K | 766.50K | 766.50K | 656.20K | 468.00K |
| Total Other Non-Cash Items | 1.98M | 2.57M | 2.36M | 3.06M | 2.24M |
| Change in Net Operating Assets | -801.80K | 61.50K | 107.20K | -2.86M | -2.44M |
| Cash from Operations | -7.25M | -5.78M | -5.41M | -6.74M | -5.63M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 5.58M | 5.58M | 5.58M | 1.50K | 29.50K |
| Total Debt Repaid | -552.40K | -146.40K | -146.40K | -2.36M | -2.36M |
| Issuance of Common Stock | 1.87M | 5.50K | -- | 100.00K | 100.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 9.73M | 9.73M |
| Cash from Financing | 6.89M | 5.44M | 5.43M | 7.47M | 7.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -356.50K | -343.80K | 19.80K | 723.60K | 1.86M |